{"disease":{"id":"virus-infections","name":"virus infections"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"active","indication_name":"Respiratory Syncytial Virus Infections","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Active","generic_name":"active","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Sisunatovir","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"rv521","indication_name":"Respiratory Syncytial Virus Infections","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"RV521","generic_name":"rv521","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"RV521 drug in capsules","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":0,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT06700941","title":"Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":8000000,"lead_sponsor_name":"Universidad Nacional de Colombia","has_results":false},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT05047900","title":"The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community","phase":"NA","overall_status":"COMPLETED","enrollment_count":70000,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT01077856","title":"GARDASIL™ Vaccine Impact in Population Study (V501-033)","phase":"","overall_status":"COMPLETED","enrollment_count":54516,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06268691","title":"Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating","phase":"NA","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Rocio Cardenas Sanchez","has_results":false},{"nct_id":"NCT01155193","title":"Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany","phase":"","overall_status":"COMPLETED","enrollment_count":30804,"lead_sponsor_name":"AbbVie (prior sponsor, Abbott)","has_results":true},{"nct_id":"NCT05407142","title":"An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":29000,"lead_sponsor_name":"Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products","has_results":false},{"nct_id":"NCT04886596","title":"Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":26675,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05238025","title":"MVA-BN-RSV Vaccine Trial","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":20419,"lead_sponsor_name":"Bavarian Nordic","has_results":true},{"nct_id":"NCT05726084","title":"Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":16304,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT03739112","title":"Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12794,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT04605159","title":"A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":11194,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06534892","title":"An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10212,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03301051","title":"Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10160,"lead_sponsor_name":"Medicago","has_results":true},{"nct_id":"NCT04623047","title":"Infection Watch Study","phase":"","overall_status":"COMPLETED","enrollment_count":10034,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03627572","title":"RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT04633603","title":"LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"University of Pecs","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04420286","title":"Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France","phase":"","overall_status":"COMPLETED","enrollment_count":9860,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT07543458","title":"Therapeutics for Moderate and Severe Dengue","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":8800,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT05285826","title":"Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8100,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05916326","title":"Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04694495","title":"HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":7500,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT05452447","title":"Spatial Repellents for Aedes-borne Virus Control in Sri Lanka","phase":"NA","overall_status":"COMPLETED","enrollment_count":6949,"lead_sponsor_name":"University of Notre Dame","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04199689","title":"Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6033,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03998254","title":"Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT04318366","title":"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Università Vita-Salute San Raffaele","has_results":false},{"nct_id":"NCT04627623","title":"Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT05244356","title":"Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation","phase":"NA","overall_status":"COMPLETED","enrollment_count":5784,"lead_sponsor_name":"Clinical Research Centre, Malaysia","has_results":false},{"nct_id":"NCT03870061","title":"Evaluation of an Infant Immunization Encouragement Program in Nigeria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5187,"lead_sponsor_name":"GiveWell","has_results":false},{"nct_id":"NCT05394623","title":"Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03614676","title":"A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance","phase":"NA","overall_status":"COMPLETED","enrollment_count":4493,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04262921","title":"French COVID Cohort","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4415,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05354024","title":"Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":4400,"lead_sponsor_name":"Butantan Institute","has_results":false},{"nct_id":"NCT03051789","title":"Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout","phase":"NA","overall_status":"COMPLETED","enrollment_count":4138,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT05099029","title":"A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3982,"lead_sponsor_name":"Enimmune Corporation","has_results":false},{"nct_id":"NCT05705440","title":"A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3855,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03979313","title":"A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3012,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT06263439","title":"Surveillance of HFMD in Pediatric Outpatients","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03210363","title":"Sero-epidemiology of Priority Arboviruses in French Guiana","phase":"NA","overall_status":"COMPLETED","enrollment_count":2697,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT06551181","title":"A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2621,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03110770","title":"VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2428,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06083623","title":"A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":2282,"lead_sponsor_name":"Zhuhai Trinomab Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03675256","title":"The KEN SHE Study on HPV-vaccine Efficacy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2275,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01868399","title":"Pilot Survey of Dengue Fever in Solomon Islands","phase":"","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","has_results":false},{"nct_id":"NCT03486834","title":"V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04000503","title":"Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2019,"lead_sponsor_name":"University of British Columbia","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}